Vinva Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4M Buy
31,174
+19,855
+175% +$12.7M 0.22% 114
2025
Q4
$7.72M Buy
11,319
+3,702
+49% +$2.52M 0.1% 177
2025
Q3
$4.8M Sell
7,617
-22,172
-74% -$13.5M 0.09% 185
2025
Q2
$15.8M Sell
29,789
-176
-0.6% -$84.2K 0.41% 57
2025
Q1
$12.5M Buy
29,965
+12,327
+70% +$5.35M 0.5% 46
2024
Q4
$7.28M Buy
17,638
+14,169
+408% +$6.21M 0.28% 82
2024
Q3
$1.78M Buy
3,469
+385
+12% +$187K 0.08% 237
2024
Q2
$1.52M Sell
3,084
-180
-6% -$90.4K 0.08% 240
2024
Q1
$1.76M Sell
3,264
-435
-12% -$238K 0.1% 221
2023
Q4
$2.06M Sell
3,699
-8,916
-71% -$4.19M 0.14% 170
2023
Q3
$5.51M Sell
12,615
-4,270
-25% -$2.13M 0.51% 43
2023
Q2
$8.35M Buy
16,885
+6,165
+58% +$2.95M 0.72% 28
2023
Q1
$5.29M Buy
+10,720
New +$5.13M 0.44% 58

Other funds holding IDXX

Vinva Investment Management's IDXX Position: Q1 2026 in Review

Vinva Investment Management increased its Idexx Laboratories (IDXX) stake by 175% in Q1 2026, buying an estimated $12.7M and bringing the position to 31,174 shares worth $17.4M. The position accounts for 0.22% of the portfolio, ranked #114.

Vinva Investment Management first reported a position in IDXX in Q1 2023 and has held it in 13 quarters since. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Vinva Investment Management held 31,174 shares of Idexx Laboratories worth $17.4M as of Q1 2026.
  • Vinva Investment Management bought 19,855 Idexx Laboratories shares in Q1 2026, an estimated $12.7M.
  • Idexx Laboratories made up 0.22% of Vinva Investment Management's portfolio in Q1 2026, its #114 holding.
  • Vinva Investment Management first reported a position in Idexx Laboratories in Q1 2023 and has held it in 13 quarters since.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.